What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Genetics
Ammar Al-Chalabi focuses on Amyotrophic lateral sclerosis, Genetics, Genome-wide association study, Single-nucleotide polymorphism and Disease.
Amyotrophic lateral sclerosis is a subfield of Internal medicine that he tackles.
His Genome-wide association study research incorporates themes from SNP, Alzheimer's disease, Linkage disequilibrium and Genetic association.
The various areas that Ammar Al-Chalabi examines in his Single-nucleotide polymorphism study include Odds ratio, Apolipoprotein E and Allele.
His Disease research is multidisciplinary, incorporating perspectives in Dermatology and Gene–environment interaction.
His TARDBP research includes elements of C9orf72, UBQLN2 and Neurodegeneration.
His most cited work include:
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (2556 citations)
- TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis (1926 citations)
- Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 (1861 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Amyotrophic lateral sclerosis, Genetics, Disease, Internal medicine and Neuroscience.
His biological study deals with issues like C9orf72, which deal with fields such as TARDBP.
His Genome-wide association study, Single-nucleotide polymorphism, Locus, Genetic association and Haplotype investigations are all subjects of Genetics research.
Genome-wide association study is frequently linked to Linkage disequilibrium in his study.
His study of Motor neuron is a part of Disease.
His research in Internal medicine intersects with topics in Endocrinology and Oncology.
He most often published in these fields:
- Amyotrophic lateral sclerosis (78.05%)
- Genetics (38.15%)
- Disease (20.45%)
What were the highlights of his more recent work (between 2018-2021)?
- Amyotrophic lateral sclerosis (78.05%)
- Genetics (38.15%)
- Disease (20.45%)
In recent papers he was focusing on the following fields of study:
Ammar Al-Chalabi mostly deals with Amyotrophic lateral sclerosis, Genetics, Disease, Gene and Internal medicine.
He has researched Amyotrophic lateral sclerosis in several fields, including Exome sequencing, Phenotype, Demography, Neuroscience and Cohort.
His study in Genetics concentrates on Genome-wide association study, Exon, C9orf72, Genetic association and Trinucleotide repeat expansion.
His biological study spans a wide range of topics, including Family history and Mendelian inheritance.
His work carried out in the field of Gene brings together such families of science as Machine learning and Neuron.
In general Internal medicine, his work in Adverse effect and Stage is often linked to Dolutegravir and Abacavir linking many areas of study.
Between 2018 and 2021, his most popular works were:
- Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7 , encoding a heat-shock protein (35 citations)
- Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7 , encoding a heat-shock protein (35 citations)
- A proposal for new diagnostic criteria for ALS. (30 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Disease
Ammar Al-Chalabi mainly investigates Amyotrophic lateral sclerosis, Genetics, Trinucleotide repeat expansion, Clinical trial and Disease.
Amyotrophic lateral sclerosis is the subject of his research, which falls under Internal medicine.
As part of his studies on Genetics, Ammar Al-Chalabi often connects relevant areas like Endogeny.
His Clinical trial study combines topics from a wide range of disciplines, such as Gastrostomy, Radiology, Patient stratification and Intensive care medicine.
His work on Disease progression is typically connected to Clinical Practice as part of general Disease study, connecting several disciplines of science.
His study in C9orf72 is interdisciplinary in nature, drawing from both Phenotype, Disease Association and Protein TDP-43.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
